Abiopharma

🔍 Krawczyk Daniel M. (Director)

Company: RAYONIER ADVANCED MATERIALS INC. (RYAM)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 104,540 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-22 | Code: A | Expires: 2029-06-22 | Exercise: 2029-06-22 | equity_swap_involved: 0 | shares_owned_after: 104,540.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 202,184 shares of Performance-Based LPUs (Derivative)
  Date: 2026-06-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 202,184.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4, F5, F5

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.
• F2: The Leveraged Performance Units ("LPUs") were granted as an employment inducement award pursuant to NYSE Listed Company Manual Rule 303A.08 in connection with the Reporting Person's commencement of employment as President and Chief Executive Officer. The award was not granted under the Company's stockholder-approved equity incentive plan.
• F3: Each LPU represents a contingent right to receive one share of Rayonier Advanced Materials Inc. common stock upon vesting, subject to the achievement of specified performance criteria and continued employment.
• F4: The number of shares ultimately earned may range from 0% to 250% of the target award based on the Company's stock price appreciation during the three-year performance period. The target award reported herein consists of 202,184 LPUs.
• F5: N/A